Metaphore is harnessing the power of biomimicry and machine learning to unlock the transformative therapeutic potential of functional molecular mimics.

Joined December 2022
Metaphore Biotechnologies retweeted
Flagship’s annual celebration of International Day of Women and Girls in Science brings together women and allies from across the Flagship ecosystem. This year, Angela Hwang, Flagship CEO-Partner & CEO of #FlagshipFounded @MetaphoreBio, joined @ChristineHeenan, Flagship Executive Partner, Executive Operations, for an inspiring conversation about Angela’s leadership journey from growing up in apartheid South Africa to leading the launch of Pfizer’s COVID-19 vaccine and lessons learned along the way. Catch their full event here: bit.ly/4b3jo8t For more from women leaders at Flagship: flagshippioneering.com/topic… #IDWGS #WomenInScience #WomenInSTEM
1
1
2
694
Metaphore Biotechnologies retweeted
Hear from the CEOs and leaders of #FlagshipFounded companies as they share the latest platform & pipeline updates, the therapeutic areas they’re focused on, new & expanded partnerships, how they’re building company culture, and what’s ahead for 2024. Watch all the latest CEO Chats here: bit.ly/48LWm3t #FlagshipJPM #JPM24
5
1
9
1,740
Metaphore Biotechnologies retweeted
From the Flagship Studio at #JPM24: Metaphore Co-founder & CEO @afzelius_lovisa on the inspiration for the company’s unique approach to molecular mimicry and how @MetaphoreBio is leveraging the interplay between AI and biology. More here: flagshippioneering.com/stori… #FlagshipJPM
1
4
759
Metaphore Biotechnologies retweeted
Metaphore Biotechnologies leverages the concept of biomimicry for developing new drugs with potential applications in autoimmune diseases, metabolic disorders, and cancer. Flagship Pioneering is backing the startup with $50 million. ow.ly/bHts104H629
1
1
311